REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Otsuka and Lundbeck Receive the US FDA's Approval for Rexulti (brexpiprazole) sNDA to Treat Agitation Associated with Dementia Due to Alzheimer's Disease

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

Alarm as FDA fast-tracks first antipsychotic drug for agitation in dementia

Dementia: FDA fast-tracks approval for antipsychotic drug Rexulti

FDA Approves the First Drug for Alzheimer's Agitation: Rexulti

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

This Antipsychotic Drug Can Now Be Used to Treat Agitation in Alzheimer's Patients

REXULTI® (Brexpiprazole) FDA Approved for Treating Agitation in Alzheimer's Disease Patients